Our 1993 paper entitled "The C. elegans Cell Death Gene ced-3 Encodes a Protein Similar to Mammalian Interleukin-l-13-Converting Enzyme" (Yuan et al., 1993) announced the discovery of a molecular mechanism for programmed cell death in the nematode Caenorhabditis elegans and led us to suggest that this mechanism is likely conserved in mammals. Our first glimpse of the impact this paper would hav...

Drosophila germ cells form at the posterior pole of the embryo and migrate to the somatic gonad. Approximately 50% of the germ cells that form reach their target. The errant cells within the embryo undergo developmentally regulated cell death. Prior studies have identified some autosomal genes that regulate germ cell migration, but the genes that control germ cell death are not known. To identi...

Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...

Objective: In this review, we aimed to discuss the efficacy of immunotherapy anti-programmed cell death protein 1 (PD-1) and programmed ligand (PD-L1) potential immune mechanism combination with various standard systemic therapies for breast cancer (BC) such as chemotherapy, targeted therapy, endocrine radiotherapy.